We're
launching our first official organizational t-shirt
in time for Awareness Month. To mark the occasion,
we want to invite you-our members, family and
friends-to have your hand in the creation of the
new shirt design!
We're
looking for a design that incorporates our logo
and color scheme. Artists can also create catch-phrases
or slogans both new and old (i.e. "the other high
blood pressure"). Winner will receive a free organizational
t-shirt in their size and a mention on our website
and online and print newsletters. The contest
closes on October 31, 2005 by Midnight EST. Any
entries
received after this date will not be qualified.
TUESDAY, Oct. 4 (HealthDay News) -- Two studies find that the
pulmonary artery catheters used to monitor the condition
of critically ill heart patients do no harm but don't
improve outcomes.
Yet the senior authors of both reports
in the Oct. 5 issue of the Journal of the American
Medical Association said they see good reason for
using the catheters in many cases.
Vandy patient brings laughter into ICU while awaiting transplant
Her fun-loving attitude camouflages the very serious battle she's fighting. She's been diagnosed with primary pulmonary hypertension. The disease, also called PPH, affects the small blood vessels in the lungs, leading to heart failure. Only one or two people in a million get it, unless you're in Sierra's family.
Pulmonary
Hypertension - A Patient's Survival Guide The premiere information resource
for people dealing with PH -- they have ARRIVED and are ready to
ship!!!
The author, a PH patient herself,
knows what it is like to live with the disease. She talked to many
other patients, doctors, and researchers while writing the Survival
Guide. Dr. Ronald J. Oudiz and a team of physicians with a deep
knowledge of PH edited the book for accuracy.
New edition contains a chart
of 15 drugs used to treat PH; results of recent
clinical trials;
in-depth discussion of PH secondary to other diseases
or conditions;
a new chapter on what to eat if you have PH; and much, much more!
Respironics Receives 510(k) Clearance From FDA for I-neb(TM) AAD(R) System
MURRYSVILLE, Pa., Sept. 28 /PRNewswire-FirstCall/ -- Respironics, Inc.
(Nasdaq: RESP) announced today the U.S. Food and Drug Administration (FDA)
granted 510(k) clearance of the I-neb Adaptive Aerosol Delivery (AAD) System
for the aerosolization of liquid medication approved for use with the I-neb
AAD System. The device is cleared for use by the patient in the home care,
nursing home, sub-acute institution, or hospital environment.
WEDNESDAY, Sept. 28 (HealthDay News) -- Gleevec, a medication experts have hailed as a wonder drug in the fight against certain cancers, may also come to the rescue of patients battling lethal pulmonary hypertension.
For
Medical Professionals:
With the advent of new PH drugs and treatments, more
and more doctors are becoming increasingly involved
in the PH community. PHA has responded to this, and
will bring together world-renowned leading PH specialists
to lead Medical Education Sessions for their peers
during the fall in six cities: New York; Atlanta;
Chicago; Seattle; Dallas; and Washington, DC.
Physicians
who participate
are eligible to receive CME credits. Educational credits
will also be available for nurses and pharmacists.
For questions
or to register by phone, please call 858-717-2940.
For Patients:
While we are bringing together leading specialists
and interested medical professionals for the Medical
Education Sessions, we know that patients will also
greatly benefit from these gatherings. We are therefore
very excited to announce PHA's Regional Patient Education
Sessions.
Many of the medical professionals presenting earlier
during the day will stay for the evening's PHA Regional
Patient Education Session to participate in a dinner,
educational slide-show and panel discussion of current
advances in PH. Kim Bernstein, director of ACCESS,
will also be at each session, presenting on insurance
issues and how to use her program as an important
resource.
Partnering with Actelion and Accredo
Therapeutics we are able to allow a free ticket to
each patient and one guest (a $50 value), up to the
first 200 registrants. This includes dinner and the
presentations. Any additional guests or registrations
after the first 200, will need to purchase a ticket
at $25. PH patients with Scleroderma are also invited
to attend a Scleroderma Support Group meeting taking
place earlier in the day.
PHA thanks Actelion, our primary sponsor,
and Accredo Therapeutics for their generous support
of this program.
The
information provided on the PHA website is provided for general information
only. It is not intended as legal, medical or other professional
advice, and should not be relied upon as a substitute for consultations
with qualified professionals who are familiar with your individual
needs.